Clinical Trial Update: Voyager I: Patient Discharge Using the AB5000 Portable Driver System [Phase 3]

View source ↗

Summary

The Phase 3 Voyager I trial evaluating the AB5000 Portable Driver System for acute cardiac dysfunction was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Dysfunction

Drugs mentioned

• AB5000 Portable Driver System

Snippet

Sponsor: Abiomed Inc. | Conditions: Acute Cardiac Dysfunction | Phase 3 | Status: TERMINATED